Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Tumor hypoxia")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 40

  • Page / 2
Export

Selection :

  • and

99mTc/Re complexes bearing bisnitroimidazole or mononitroimidazole as potential bioreductive markers for tumor: Synthesis, physicochemical characterization and biological evaluationLEI MEI; YUE WANG; TAIWEI CHU et al.European journal of medicinal chemistry. 2012, Vol 58, pp 50-63, issn 0223-5234, 14 p.Article

Evaluation of hypoxia-inducible factor-1α (HIF-1α) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: In vitro and xenograft studiesVORDERMARK, Dirk; MARTIN BROWN, J.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 4, pp 1184-1193, issn 0360-3016, 10 p.Article

Polarographic electrode study of tumor oxygenation in clinically localized prostate cancerPARKER, Chris; MILOSEVIC, Michael; MCLEAN, Michael et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 750-757, issn 0360-3016, 8 p.Article

Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxiaAKURATHI, Vamsidhar; DUBOIS, Ludwig; LIEUWES, Natasja G et al.Nuclear medicine and biology. 2010, Vol 37, Num 5, pp 557-564, issn 0969-8051, 8 p.Article

Structure―activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agentJIYOUNG MUN; ABDUL JABBER, Adnan; SAROJINI DEVI, Narra et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 14, pp 4590-4597, issn 0968-0896, 8 p.Article

TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedulesQIAN LIU; SUN, Jessica D; CURD, John G et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 6, pp 1487-1498, issn 0344-5704, 12 p.Article

HPMA copolymers for modulating cellular signaling and overcoming multidrug resistanceMINKO, Tamara.Advanced drug delivery reviews. 2010, Vol 62, Num 2, pp 192-202, issn 0169-409X, 11 p.Article

Imaging Tumor Oxyhemoglobin and Deoxyhemoglobin Concentrations with Ultrasound-Guided Diffuse Optical Tomography : Advances in Optical Imaging in Cancer Research: Part 1BISWAL, Nrusingh C; YAN XU; QUING ZHU et al.Technology in cancer research & treatment (Print). 2011, Vol 10, Num 5, pp 417-429, issn 1533-0346, 13 p.Article

Synthesis and evaluation of a novel 99mTc-labeled bioreductive probe for tumor hypoxia imagingKIMURA, Sadaaki; UMEDA, Izumi O; MORIYAMA, Noriyuki et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 24, pp 7359-7362, issn 0960-894X, 4 p.Article

Detection and Specific Targeting of Hypoxic Regions within Solid Tumors : Current Preclinical and Clinical StrategiesBACHE, M; KAPPLER, M; SAID, H. M et al.Current medicinal chemistry. 2008, Vol 15, Num 4, pp 322-338, issn 0929-8673, 17 p.Article

Multi-modal strategies for overcoming tumor drug resistance: Hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnologyMILANE, Lara; GANESH, Shanthi; SHAH, Shruti et al.Journal of controlled release. 2011, Vol 155, Num 2, pp 237-247, issn 0168-3659, 11 p.Conference Paper

DNA strand cleaving properties and hypoxia-selective cytotoxicity of 7-chloro-2-thienylcarbonyl-3-trifluoromethylquinoxaline 1,4-dioxideJUNNOTULA, Venkatraman; RAJAPAKSE, Anuruddha; ARBILLAGA, Leire et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 9, pp 3125-3132, issn 0968-0896, 8 p.Article

Advances in methods for assessing tumor hypoxia in vivo : Implications for treatment planningDAVDA, Sonal; BEZABEH, Tedros.Cancer metastasis reviews. 2006, Vol 25, Num 3, pp 469-480, issn 0167-7659, 12 p.Article

Expression of EGFR Under Tumor Hypoxia: Identification of a Subpopulation of Tumor Cells Responsible for Aggressiveness and Treatment ResistanceHOOGSTEEN, Use J; MARRES, Henri A. M; DEN HOOGEN, Franciscus J. A. Van et al.International journal of radiation oncology, biology, physics. 2012, Vol 84, Num 3, pp 807-814, issn 0360-3016, 8 p.Article

Eicosanoids and other lipid mediators and the tumor hypoxic microenvironmentKRISHNAMOORTHY, Sriram; HONN, Kenneth V.Cancer metastasis reviews. 2011, Vol 30, Num 3-4, pp 613-618, issn 0167-7659, 6 p.Article

Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinomaZHUANG, Peng-Yuan; ZHANG, Ju-Bo; TANG, Zhao-You et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 12, pp 1891-1900, issn 0171-5216, 10 p.Article

Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumorsHARDEE, Matthew E; EAPEN, Rose J; RABBANI, Zahid N et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 2, pp 219-228, issn 0344-5704, 10 p.Article

The HIF-1-active microenvironment: An environmental target for cancer therapyKIZAKA-KONDOH, Shinae; TANAKA, Shotaro; HARADA, Hiroshi et al.Advanced drug delivery reviews. 2009, Vol 61, Num 7-8, pp 623-632, issn 0169-409X, 10 p.Article

Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancerSEOK JIN KIM; RABBANI, Zahid N; DEWHIRST, Mark W et al.Lung cancer. 2005, Vol 49, Num 3, pp 325-335, issn 0169-5002, 11 p.Article

Synthesis and biological evaluation of novel bis-aziridinylnaphthoquinone derivativesHUANG, Sheng-Tung; KUO, Hsien-Shou; LIN, Chun-Mao et al.Oncology research. 2003, Vol 13, Num 4, pp 199-204, issn 0965-0407, 6 p.Article

Significance of HIF-1-active cells in angiogenesis and radioresistanceHARADA, H; KIZAKA-KONDOH, S; LI, G et al.Oncogene (Basingstoke). 2007, Vol 26, Num 54, pp 7508-7516, issn 0950-9232, 9 p.Article

Effect of Artificial Oxygen Carrier with Chemotherapy on Tumor Hypoxia and NeovascularizationJIANQUN HAN; MINGHUA YU; MIN DAI et al.Artificial cells, blood substitutes, and biotechnology. 2008, Vol 36, Num 5, pp 431-438, 8 p.Article

Glucose metabolism of malignant cells is not regulated by transketolase-like (TKTL)-1MAYER, Arnulf; VON WALLBRUNN, Angelika; VAUPEL, Peter et al.International journal of oncology. 2010, Vol 37, Num 2, pp 265-271, issn 1019-6439, 7 p.Article

Inhibitory effect of a naphthazarin derivative, S64, on heat shock factor (Hsf) activation and glutathione status following hypoxiaPARK, E.-M; LEE, I.-J; KIM, S.-H et al.Cell biology and toxicology. 2003, Vol 19, Num 5, pp 273-284, issn 0742-2091, 12 p.Article

Endogenous markers of tumor hypoxia: Predictors of clinical radiation resistance?VORDERMARK, Dirk; BROWN, J. Martin.Strahlentherapie und Onkologie. 2003, Vol 179, Num 12, pp 801-811, issn 0179-7158, 11 p.Article

  • Page / 2